fbpx
June 9, 2020

organic-beauty-recipes.com – 607753 – 06/08/2020

Product: Drugs Date:               June 8, 2020 CC:                  [email protected] – Amazon Associates Program RE:                  Unapproved and Misbranded Products Related to Coronavirus Disease 2019 […]
June 9, 2020

Coronavirus (COVID-19) Update: Daily Roundup June 8, 2020

For Immediate Release: June 08, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 […]
June 8, 2020

CURE ID App Lets Clinicians Report Novel Uses of Existing Drugs

CURE ID is an internet-based repository that lets the clinical community report novel uses of existing drugs for difficult-to-treat infectious diseases through a website, a smartphone […]
June 8, 2020

Sciegen Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Irbesartan Tablets, USP 75 Mg, 150 Mg, and 300 Mg Due to The Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in The Active Pharmaceutical Ingredient (API)

Summary Company Announcement Date: October 30, 2018 FDA Publish Date: May 03, 2019 Product Type: DrugsPrescription Drugs Reason for Announcement: Recall Reason Description Due to detection […]
June 8, 2020

Innovation to Respond to COVID-19

Learn about FDA’s innovative approaches to respond to COVID-19 as quickly and safely as possible. FDA Efforts to Connect Manufacturers and Health Care Entities: The FDA, […]
June 8, 2020

Organic Herbal Supply Issues Voluntary Nationwide Recall Of All Lots Of Various Supplements For Male And Female Sexual Enhancement Due To Undeclared Active Ingredients

Summary Company Announcement Date: April 18, 2017 FDA Publish Date: February 08, 2018 Product Type: Drugs Reason for Announcement: Recall Reason Description Undeclared Active Ingredients tadalafil, […]
June 8, 2020

Temporary Policy on Prescription Drug Marketing Act Requirements for Distribution of Drug Samples During the COVID-19 Public Health Emergency

Docket Number: FDA-2020-D-1136 Issued by: Guidance Issuing Office Center for Drug Evaluation and Research FDA plays a critical role in protecting the United States from threats […]
June 8, 2020

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration

Summary Company Announcement Date: August 08, 2018 FDA Publish Date: March 20, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description Due to Risk of […]
June 8, 2020

Torrent Pharmaceuticals Limited Issues Voluntary Nationwide Recall of Valsartan / Amlodipine / HCTZ Tablets

Summary Company Announcement Date: August 17, 2018 FDA Publish Date: March 20, 2020 Product Type: DrugsPrescription Drugs Reason for Announcement: Recall Reason Description Due to The […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0